Stanford ChEM-H Institute Scholar Michael Fischbach explains why the microbiome is worth studying, the ways his lab hopes to advance our understanding of these complex communities, and how the people and mission of ChEM-H drew him to Stanford.
Stanford researchers have identified immune cells that help reduce the severity of a disease in mice akin to multiple sclerosis. These cells could one day be useful therapeutic targets in treating autoimmune diseases.
Stanford researchers have uncovered how a genetic mutation contributes to a heart disease known as familial dilated cardiomyopathy. Existing drugs correct the defect in heart cells grown in a petri dish, suggesting a new therapeutic target.
For years, researchers studied key enzymes in largely piecemeal fashion. Now, Stanford researchers are using new techniques to explore previously inaccessible aspects of the molecules that make life happen.